Brexpiprazole versus placebo or other antidepressive agents for treating depression

Ralovska S., Koychev I., De Crescenzo F., Marinov P., Cipriani A.

Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To investigate the efficacy, tolerability, acceptability, and safety of brexpiprazole as monotherapy or adjunct treatment in the acute- and long-term treatment of major depression.

DOI

10.1002/14651858.CD013866

Type

Journal article

Journal

Cochrane Database of Systematic Reviews

Publication Date

05/02/2021

Volume

2021

Permalink Original publication